Posted on by IO

Renal ablation articles

  1. Askarpour, M, Aminsharifi, A. Minimally Invasive Salvage Approaches for Management of Recurrence After Primary Renal Mass Ablation. Cancers (Basel). 2025;17 (6):. doi: 10.3390/cancers17060974. PubMed PMID:40149308 PubMed Central PMC11940802.
  2. Chan, VW, Ng, HH, Abdulrauf, K, Zaman, H, Ahmed, A, Zhong, J et al.. Percutaneous Image-Guided Ablation of Renal Cancer: Traditional and Emerging Indications, Energy Sources, Techniques, and Future Developments. Medicina (Kaunas). 2025;61 (3):. doi: 10.3390/medicina61030438. PubMed PMID:40142250 PubMed Central PMC11943572.
  3. Baer, BR, Matheny, MV, Mercedes, RH, Raman, JD. Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy. Curr Oncol. 2025;32 (3):. doi: 10.3390/curroncol32030125. PubMed PMID:40136329 PubMed Central PMC11940996.
  4. Travesso, DJ, de Melo, RAB, Almeida, MFA, Motta-Leal-Filho, JM, Moura, EBS, Machado, F et al.. T1b Renal Masses Radiofrequency Ablation: Feasibility, Safety, and Efficacy in Midterm Follow-Up. Int J Urol. 2025; :. doi: 10.1111/iju.70042. PubMed PMID:40062605 .
  5. Cassim, R, Bansal, R, Millan, B, Mironov, O, Ahir, P, Tajzler, C et al.. A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER). Urology. 2025; :. doi: 10.1016/j.urology.2025.02.053. PubMed PMID:40058468 .
  6. Schaarschmidt, BM, Zensen, S, Kesch, C, Dertnig, T, Opitz, M, Drews, M et al.. Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy. Eur Radiol. 2025;35 (3):1723-1731. doi: 10.1007/s00330-024-11343-w. PubMed PMID:40016555 PubMed Central PMC11868359.
  7. Carbonara, U, Ditonno, F, Beksac, AT, Derweesh, I, Cerrato, C, Celia, A et al.. Percutaneous Cryotherapy and Radiofrequency Ablation of Renal Masses: Multicenter Comparative Analysis with Minimum 3-Year Follow-up. Int Braz J Urol. 2025;51 (2):. doi: 10.1590/S1677-5538.IBJU.2024.0565. PubMed PMID:39913094 PubMed Central PMC11884627.
  8. Wells, SA, Shapiro, D, Borza, T, Allen, G, Hinshaw, JL, Ziemlewicz, TJ et al.. Percutaneous microwave ablation of cT1b renal cell carcinoma: safety and oncologic efficacy in a large, single-center elderly and comorbid cohort. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04794-8. PubMed PMID:39912925 .
  9. Li, G, Chen, Y, Zhang, X. Percutaneous laser ablation vs. radical nephroureterectomy: a comparative study on renal pelvic tumors. Int Urol Nephrol. 2025; :. doi: 10.1007/s11255-025-04395-4. PubMed PMID:39904823 .
  10. Elhakim, TS, Lodhi, T, Fidelis, W, Brea, A, Mort, A, Mohagheghtabar, M et al.. Management of renal cell carcinoma with ablation in comparison to nephrectomy: A 5-year analysis of inpatient procedural data to evaluate utilization disparities in the United States. Clin Imaging. 2025;119 :110412. doi: 10.1016/j.clinimag.2025.110412. PubMed PMID:39862649 .
  11. Ochsner, A, Malshy, K, Golijanin, B, Mega, A, Collins, S, Maxwell, A et al.. Adrenal Metastasis Ablation in Oligometastatic Renal Cell Carcinoma: A Case Series. Clin Genitourin Cancer. 2025;23 (2):102295. doi: 10.1016/j.clgc.2024.102295. PubMed PMID:39854956 .
  12. Justo-Jaume, C, Stempel, M, Qiu, J, Gonzalez Miranda, L, Yan, G, Lyons, G et al.. Efficacy and safety of microwave ablation in solitary kidney patients with T1a small renal masses. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04779-7. PubMed PMID:39775024 .
  13. Tyagi, SC. Epigenetics of Homocystinuria, Hydrogen Sulfide, and Circadian Clock Ablation in Cardiovascular-Renal Disease. Curr Issues Mol Biol. 2024;46 (12):13783-13797. doi: 10.3390/cimb46120824. PubMed PMID:39727952 PubMed Central PMC11726923.
  14. Hasegawa, T, Vroomen, LGPH, Sivaraman, A, Fujimori, M, John, NT, Coleman, J et al.. Effect of Transforming Growth Factor-β Inhibition on Ureteral and Renal Scarring in a Rat Model of Upper Urinary Tract Ablation with Irreversible Electroporation. Bioelectricity. 2024;6 (4):272-279. doi: 10.1089/bioe.2024.0022. PubMed PMID:39712219 PubMed Central PMC11656016.
  15. Ravizzini, PI, Lino, HA, Ravizzini, G, Toledo, LGM. Percutaneous radiofrequency ablation of an actively bleeding renal angiomyolipoma. Einstein (Sao Paulo). 2024;22 :eRC1008. doi: 10.31744/einstein_journal/2024RC1008. PubMed PMID:39699407 PubMed Central PMC11634353.
  16. Zhou, V, Zhou, W, Herwald, SE, Arellano, RS. CT-guided microwave ablation of renal cell carcinoma in a horseshoe kidney. Radiol Case Rep. 2025;20 (2):1030-1033. doi: 10.1016/j.radcr.2024.10.142. PubMed PMID:39654582 PubMed Central PMC11626640.
  17. Yang, B, Zheng, Y, Zheng, M, Wang, D, Ren, S, Tian, J et al.. Partial nephrectomy versus radiofrequency ablation in patients with cT1a renal cell carcinoma: A surveillance, epidemiology, end results (SEER) analysis. Medicine (Baltimore). 2024;103 (48):e40721. doi: 10.1097/MD.0000000000040721. PubMed PMID:39612442 PubMed Central PMC11608729.
  18. Lucignani, G, Rizzo, M, Ierardi, AM, Piasentin, A, De Lorenzis, E, Trombetta, C et al.. A Trifecta-Based Evaluation of Patients Treated with Percutaneous Thermal Ablation of Small Renal Masses. J Endourol. 2025;39 (S2):S38-S45. doi: 10.1089/end.2024.0091.fts24. PubMed PMID:39612165 .
  19. Becher, E. Editorial Comment on A Trifecta-Based Evaluation of Patients Treated with Percutaneous Thermal Ablation of Small Renal Masses by G. Lucignani, et. al. J Endourol. 2025;39 (S2):S46. doi: 10.1089/end.2024.0767. PubMed PMID:39588916 .
  20. do Carmo, LV, Pereira, KD, Goulart, MA, Laurinavicius, AG, Souza, J, Junior, OP et al.. Blood Pressure Control and Clinical Outcomes After Renal Denervation Through Irrigated Catheter Radiofrequency Ablation in Patients with Resistant Hypertension: A Case Series with Up to 10 Years of Follow-Up. High Blood Press Cardiovasc Prev. 2024;31 (6):687-694. doi: 10.1007/s40292-024-00685-7. PubMed PMID:39557771 .
Search PubMed